Get the Stockscreener App
2.857
2.13%
0.037
Seastar Medical Holding Corp stock is traded at $2.857, with a volume of 95,767.
It is up +2.13% in the last 24 hours and down -32.71% over the past month.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
See More
Previous Close:
$2.82
Open:
$2.81
24h Volume:
95,767
Relative Volume:
1.27
Market Cap:
$11.82M
Revenue:
-
Net Income/Loss:
$-26.23M
P/E Ratio:
-3.1282
EPS:
-0.9133
Net Cash Flow:
$-10.29M
1W Performance:
-14.03%
1M Performance:
-32.71%
6M Performance:
-74.32%
1Y Performance:
-86.22%
1-Day Range:
$2.7301
$2.9412
1-Week Range:
$2.7301
$3.4593
52-Week Range:
$2.7301
$42.92
Seastar Medical Holding Corp Stock (ICU) Company Profile
Name
Seastar Medical Holding Corp
Sector
Industry
Phone
844-427-8100
Address
3513 BRIGHTON BLVD, DENVER
Seastar Medical Holding Corp Stock (ICU) Latest News
Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial - GlobeNewswire
SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE - Yahoo Finance
ICUSeaStar Medical Holding Corporation Latest Stock News & Market Updates - StockTitan
Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024Update - Yahoo Finance
SeaStar Medical Announces that Stanford Medicine is Cleared - GlobeNewswire
Seastar Medical settles dispute with Nuwellis for $900K - Investing.com
Seastar Medical settles dispute with Nuwellis for $900K By Investing.com - Investing.com UK
SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers - GlobeNewswire
SeaStar Medical's NEUTRALIZE-AKI trial surpasses halfway mark - Investing.com
SeaStar Medical's NEUTRALIZE-AKI trial surpasses halfway mark By Investing.com - Investing.com South Africa
SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis - GlobeNewswire
SeaStar Medical to Showcase New Mechanistic Data - GlobeNewswire
SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit - GlobeNewswire
SeaStar Medical expands trial sites for kidney injury device - Investing.com
SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities - GlobeNewswire
SeaStar medical executive buys $4.3k in company stock By Investing.com - Investing.com Australia
SeaStar medical executive buys $4.3k in company stock - Investing.com
SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial - GlobeNewswire
Seaport Entertainment Group Announces Commencement of Rights Offering - StockTitan
SEA (NYSE:SE) Shares Gap Up After Analyst Upgrade - Defense World
Sea Limited (NYSE:SE) Stake Decreased by HighVista Strategies LLC - Defense World
Sea Limited (NYSE:SE) Shares Sold by Itau Unibanco Holding S.A. - Defense World
Skandinaviska Enskilda Banken AB publ Has $4.09 Million Position in Sea Limited (NYSE:SE) - Defense World
SeaChange International (NASDAQ:SEAC) Coverage Initiated at StockNews.com - Defense World
Sea Limited (NYSE:SE) Shares Bought by Sei Investments Co. - Defense World
SEA (NYSE:SE) Hits New 1-Year High at $84.60 - Defense World
Why the Market Dipped But Sea Limited Sponsored ADR (SE) Gained Today - Yahoo Finance
SEA (NYSE:SE) Sets New 1-Year High at $84.60 - MarketBeat
Closing Bell Recap: Seelos Therapeutics Inc (SEEL) Ends at 0.20, Reflecting a -11.51 Downturn - The Dwinnex
Sea Limited stock soars to 52-week high of $85.16 By Investing.com - Investing.com Australia
Sea Limited stock soars to 52-week high of $85.16 - Investing.com
Parallel Advisors LLC Purchases 250 Shares of Sea Limited (NYSE:SE) - Defense World
Sea Limited (NYSE:SE) Receives $80.00 Average Target Price from Analysts - MarketBeat
Sea Limited (NYSE:SE) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Daiwa Securities Group Inc. Boosts Stake in Sea Limited (NYSE:SE) - Defense World
Ballentine Partners LLC Acquires Shares of 2,962 Sea Limited (NYSE:SE) - Defense World
Rhumbline Advisers Cuts Position in Sea Limited (NYSE:SE) - Defense World
SeaStar Medical (NASDAQ:ICU) Shares Up 5.5% - Defense World
FINAL ICU DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Seastar Medical Holding Corp. Investors to Join the Class Action Lawsuit! - AccessWire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against SeaStar Medical Holding Corporation (ICU) - Business Wire
ICU Deadline: Rosen Law Firm Urges SeaStar Medical Holding Corporation (ICU, ICUCW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - The Bakersfield Californian
SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference - GlobeNewswire
SeaStar Medical Holding Corporation retires all long-term debt - Medical Buyer
2024-09-05 | Lost Money on SeaStar Medical Holding Corporation (ICU)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky | NDAQ:ICU | Press Release - Stockhouse Publishing
2024-09-04 | Investors in SeaStar Medical Holding Corporation Should Contact Levi & Korsinsky Before September 6, 2024 to Discuss Your RightsICU | NDAQ:ICU | Press Release - Stockhouse Publishing
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SeaStar - Stockhouse Publishing
SeaStar Medical eliminates all long-term debt - Investing.com
SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt - GlobeNewswire
2024-09-04 | Shareholders that lost money on SeaStar Medical Holding Corporation (ICU) should contact Levi & Korsinsky about pending Class ActionICU | NDAQ:ICU | Press Release - Stockhouse Publishing
ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit - Stockhouse Publishing
ICU DEADLINE: ROSEN, TOP RANKED NATIONAL INVESTOR - GlobeNewswire
Seastar Medical Holding Corp Stock (ICU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seastar Medical Holding Corp Stock (ICU) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Van Heel Kenneth | Director |
Nov 22 '23 |
Buy |
0.40 |
100,000 |
40,000 |
116,400 |
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):